What are the differential diagnoses of hirsutism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnoses of Hirsutism

The differential diagnosis of hirsutism includes polycystic ovary syndrome (PCOS) as the most common cause (70-80% of cases), followed by idiopathic hirsutism, nonclassical congenital adrenal hyperplasia (21-hydroxylase deficiency), androgen-secreting tumors, functional hypothalamic amenorrhea with polycystic ovarian morphology, Cushing's syndrome, hyperprolactinemia, acromegaly, and drug-induced hyperandrogenism. 1, 2, 3

Primary Endocrine Causes

Polycystic Ovary Syndrome (PCOS)

  • PCOS accounts for the vast majority of hirsutism cases, representing the most common cause of androgen excess 1, 4, 3
  • Diagnosed using Rotterdam criteria requiring 2 of 3 findings: hyperandrogenism (clinical or biochemical), ovulatory dysfunction, or polycystic ovary morphology 5, 6
  • In adolescent females, PCOS diagnosis requires hyperandrogenism plus persistent oligomenorrhea 5
  • Associated features include infrequent menses, androgenetic alopecia, infertility, clitoromegaly, and truncal obesity 5

Idiopathic Hirsutism

  • Affects 5-17% of hirsute patients depending on ethnicity and geographic area 3, 7
  • Diagnosis requires normal ovulatory function AND normal circulating androgen levels 1, 7
  • Regular menses alone are insufficient to exclude ovulatory dysfunction, as up to 40% of eumenorrheic hirsute women are anovulatory 7
  • Pathophysiology involves primary increase in skin 5α-reductase activity and possibly altered androgen receptor function 7

Nonclassical Congenital Adrenal Hyperplasia (NCCAH)

  • Accounts for 1-8% of hirsute women, primarily due to 21-hydroxylase deficiency 3
  • Can present with recalcitrant acne in both men and women 5
  • In prepubertal children, look for early-onset body odor, axillary/pubic hair, accelerated growth, advanced bone age, and genital maturation 5

Neoplastic Causes

Androgen-Secreting Tumors (Ovarian or Adrenal)

  • Life-threatening potential requires prompt identification 4, 3
  • Serum testosterone >200 ng/dL is highly suggestive of adrenal or ovarian tumor 2
  • Adrenocortical carcinomas may present with virilization including hirsutism, deepening of voice, and oligo/amenorrhea in women 5
  • Suspect malignancy if tumor has irregular morphology, is lipid-poor, does not wash out on contrast-enhanced CT, is >3 cm, or secretes multiple hormones 5

Other Endocrine Disorders

Cushing's Syndrome

  • Presents with weight gain, proximal muscle weakness, hypertension, psychiatric disturbances, hirsutism, centripetal obesity, purple striae, buffalo hump, hyperglycemia, and hypokalemia 5
  • Requires specific surgical treatment when identified 4, 3

Hyperprolactinemia

  • Must be excluded in the diagnostic workup of hirsutism 4, 3
  • Part of the differential diagnosis of PCOS 5

Acromegaly

  • Should be excluded in patients presenting with hirsutism 4, 3

Thyroid Disease

  • Part of the differential diagnosis of PCOS and hyperandrogenism 5

Functional Hypothalamic Amenorrhea with PCOM

  • Can easily be misclassified as PCOS phenotype D (PCOM plus oligo/anovulation) 5
  • Distinguished by history of weight loss, vigorous exercise, or stress 5
  • Lower serum levels of estradiol, androgens, LH, and AMH compared to PCOS 5
  • Higher SHBG levels than PCOS 5
  • Low insulin levels and normal insulin sensitivity, contrasting with insulin resistance in PCOS 5

Drug-Induced Hirsutism

  • Androgenic drug intake can cause hirsutism 1, 3
  • Must be identified in the medication history 3

Rare Causes

  • Glucocorticoid resistance syndrome 3
  • Hyperandrogenic-insulin-resistant acanthosis nigricans (HAIR-AN) syndrome affects approximately 3% of hyperandrogenic women 3

Critical Diagnostic Considerations

The most important purpose of investigation is identifying women with potentially life-threatening pathologies, particularly androgen-secreting tumors 4, 3. A systematic approach should assess for features suggesting specific etiologies:

  • Rapid onset or severe virilization suggests tumor 2, 4
  • Testosterone >200 ng/dL mandates tumor evaluation 2
  • Ovulatory dysfunction must be confirmed, not assumed from menstrual history alone 7
  • Ethnic background influences prevalence of idiopathic hirsutism and expression of androgen excess 1, 3

References

Research

The evaluation and management of hirsutism.

Obstetrics and gynecology, 2003

Research

Hirsutism: diagnosis and treatment.

Arquivos brasileiros de endocrinologia e metabologia, 2014

Research

Hirsutism - from diagnosis to use of antiandrogens.

Frontiers of hormone research, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Workup for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Idiopathic hirsutism.

Endocrine reviews, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.